Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 318,402 | 190,291 | 163,093 | 214,873 | 200,470 |
| Marketable Securities | N/A | N/A | N/A | 199,983 | 242,045 |
| Receivables | 228,502 | 241,720 | 180,310 | 146,490 | 152,287 |
| Inventories | 130,272 | 123,433 | 121,120 | 80,570 | 86,146 |
| Income taxes - deferred | 83,503 | 84,157 | 80,095 | N/A | 51,842 |
| TOTAL | $797,799 | $703,017 | $598,119 | $675,626 | $751,009 |
| Non-Current Assets | |||||
| PPE Net | 206,127 | 214,630 | 215,591 | 188,169 | 191,272 |
| Intangibles | 838,520 | 897,720 | 902,075 | 54,285 | 55,881 |
| Other Non-Current Assets | 153,430 | 216,942 | 66,478 | 161,117 | 94,008 |
| TOTAL | $1,198,077 | $1,329,292 | $1,184,144 | $403,571 | $341,161 |
| Total Assets | $1,995,876 | $2,032,309 | $1,782,263 | $1,079,197 | $1,092,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 18,741 | N/A | N/A |
| Accounts payable and accrued liabilities | 37,271 | 29,874 | 49,344 | 31,976 | 33,455 |
| Accrued Expenses | 197,314 | 195,794 | 172,629 | 125,816 | 135,060 |
| TOTAL | $235,492 | $226,575 | $244,637 | $158,699 | $170,148 |
| Non-Current Liabilities | |||||
| Long Term Debt | 419,413 | 414,391 | 398,609 | N/A | N/A |
| Deferred Revenues | 907 | 907 | 3,923 | 907 | 1,633 |
| Other Non-Current Liabilities | 146,024 | 203,964 | 38,548 | 29,218 | 30,055 |
| TOTAL | $731,719 | $818,049 | $643,300 | $32,621 | $33,521 |
| Total Liabilities | $967,211 | $1,044,624 | $887,937 | $191,320 | $203,669 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,514 | 72,305 | 71,702 | 71,330 | 71,248 |
| Common Shares | 731 | 720 | 719 | 714 | 710 |
| Retained earnings | 558,796 | 523,041 | 524,893 | 531,226 | 531,106 |
| Other shareholders' equity | -11,289 | -2,582 | -3,266 | -6,166 | -1,830 |
| TOTAL | $1,028,665 | $987,685 | $894,326 | $887,877 | $888,501 |
| Total Liabilities And Equity | $1,995,876 | $2,032,309 | $1,782,263 | $1,079,197 | $1,092,170 |